Organ transplant recipients vulnerable to COVID-19 even after vaccination, says study


PTI, May 10, 2021, 2:07 PM IST

New Delhi: Although two doses of a COVID-19 vaccine confer some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures, according to a study.

This is a follow-up study to an earlier one in which the researchers reported that only 17 per cent of the participating transplant recipients produced sufficient antibodies after just one dose of a two-dose COVID-19 vaccine regimen.

”While there was an increase in those with detectable antibodies after the second shot, the number of transplant recipients in our second study whose antibody levels reached high enough levels to ward off infection was still well below than in people with healthy immune systems,” said study lead author Brian Boyarsky from the Johns Hopkins University School of Medicine in the US.

”Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict COVID-19 safety precautions, even after vaccination,” Boyarsky said.

The researchers noted that people who receive solid organ transplants, such as hearts, lungs and kidneys, often must take drugs to suppress their immune systems and prevent rejection.

Such regimens may interfere with a transplant recipient’s ability to make antibodies to foreign substances, including the protective ones produced in response to vaccines, they said.

The latest study, published in the Journal of the American Medical Association (JAMA), evaluated this immunogenic response following the second dose of either of the two mRNA vaccines – made by Moderna and Pfizer-BioNTech – for 658 transplant recipients, none of whom had a prior diagnosis of COVID-19.

The participants completed their two-dose regimen between December 16, 2020, and March 13, 2021.

The researchers found that only 98 of the 658 study participants – 15 per cent – had detectable antibodies to SARS-CoV-2 at 21 days after the first vaccine dose.

This was comparable to the 17 per cent reported in the March study looking at the immune response after only one vaccine dose.

At 29 days following the second dose, the number of participants with detectable antibodies rose to 357 out of 658 – 54 per cent, the researchers said.

After both vaccine doses were administered, 301 out of 658 participants – 46 per cent – had no detectable antibody at all while 259 – 39 per cent – only produced antibodies after the second shot, they said.

The researchers also found that among the participants, the most likely to develop an antibody response were younger, did not take immunosuppressive regimens including anti-metabolite drugs and received the Moderna vaccine.

These were similar to the associations seen in the March single-dose study, they said.

”Given these observations, transplant recipients should not assume that two vaccine doses guarantee sufficient immunity against SARS-CoV-2 any more than it did after just one dose,” said study co-author Dorry Segev, from the Johns Hopkins University School of Medicine.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Udupi: Bike abandoned on Mabukala bridge; Owner found dead

Terror module busted in Punjab ahead of Independence Day

J K Rowling receives death threat over her tweet on Salman Rushdie attack

Militant attack in Manipur on Independence Day thwarted, 7 arrested

Security scare raised by passenger on Mumbai-bound flight at MIA; flight delayed

Minister Byrati Basavaraj’s father dies at 85

Non-inclusion of Nehru in K’taka govt ad, Siddaramaiah calls Bommai “RSS slave”


Related Articles More

WHO plans to rename monkeypox over stigmatisation concerns

Antibodies that may lead to next-gen vaccines for all Covid strains found

Indian-origin doctor honoured for making exceptional contribution to Liverpool city

3D printed spinal orthosis designed for disabled people suffering from cancer

100 mn doses of Corbevax supplied to Centre: Biological E Ltd

MUST WATCH

Relief sculpture at Ammai School Compaound

| KABBINALE | Mysterious Waterfall Of Hebri

Shri Araga Gyanendra addressed the gathering. |udayavaninews

News bulletin 13-8-2022

How to cultivate a forest concept


Latest Additions

Punjab CM Mann watches ‘Laal Singh Chaddha’, says it speaks of mutual brotherhood

Udupi: Bike abandoned on Mabukala bridge; Owner found dead

B’luru: Experts flag dubious biz model of digital small money lending apps

Maha CM Shinde refutes Uddhav’s claim of BJP going back on CM post promise in 2019

Individual effort crucial in building secure India: Yogi

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.